Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters;Difuzní idiopatická skeletální hyperostóza a souvisiost s metabolickými parametry

Vnitrni Lekarstvi

Volumn 52, Issue 5, 2006, Pages 477-480

  Pavelka, Karel ^a   Pavelková, Andrea ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Diabetes mellitus; DISH; Hyperostosis; IGF; Insulin resistance

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2;

CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPEROSTOSIS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; SKELETON MALFORMATION;

BONE AND BONES; BONE RESORPTION; DIABETES COMPLICATIONS; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; OSTEOGENESIS;

EID: 33744952488     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Smythe H, Littlejohn G. Diffuse idiopathic skeletal Hyperostosis. In: Klippel JH, Dieppe PQ. Rheumatology. St Louis: Mosby 1994; 9: 1-9.
2. Littlejohn GO, Urowitz MB. Peripheral enthesopathy in difuse idiopathic skeletal hyperostosis (DISH): a radiological study. J Rheumatol 1982; 9: 568-572.
3. Resnick D, Saul SR, Robins JM. Difuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extra spinal manifestations. Radiology 1975; 115: 513-524.
4. Jalkunen H, Heinonen OP, Knekt P et al. The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in general population. Scand J Rheumatol 1973; 40: 581-591.
5. Fortin PR, Mata S, Joseph L et al. Is difuse idiopathic skeletal hyperostosis a distinct entity? A controlled study. Arthritis Rheum 1995, 38(Suppl): 657 (abstract).
6. Kamila M, Farada A, Mizuno M et al. Association between a polymorphism of the transforming factor-beta 1 gene susceptibility to ossification of the posterior longitudinal ligament in Japanese patients. Spine 2001; 26: 1264-1266.
7. Littlejohn GO. Insulin and new bone formation in difuse idiopathic skeletal hyperostosis. Clin Rheumatol 1985; 4: 294-300.
8. Littlejohn G. DISH. In: Hochburg et al. Rheumatology. St Louis: Mosby 2003; 1863
9. Littlejohn GO, Smythe HA Marked Hyperinsulinemia after Glucose Challenge in Patients with Diffuse Idiopathic Skeletal Hyperostosis. J Rheumatol 1981; 8: 965-968.
10. Bluestone R, Bywaters EG, Hartoo M et al. Acromegalic arthropathy. Ann Rheum Dis 1971; 30: 243-250.
11. Bošák V, Žlnay D, Navrátil J et al. Imunogenetické aspekty při ankylozujúcej hyperostóze. Rheumatologia 1988, 24: 8-14.
12. Brixen K, Nielsen HK, Mosekilde L et al. A short course of rhGH stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 1990; 5: 609-618.
13. Russel RGG, Bunning RAD, Hughes DE et al. Humoral and local factors affecting bone formation and resorption. In: Stevenson JC (ed). New techniques in Metabolic Bone Disease. London: Wright 1990: 1-20.
14. Oursler MJ, Osdoby P, Pyfferoen J et al. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 1991; 88: 6613-6617.
15. Canalis E. Growth factors and their potential clinical value. J Clin Endocrinol Metab 1992; 75: 1-4.
16. Lian JB, Stein GS, Canalis E et al. Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and mineralization process. In: Favus MJ (ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 1999: 14-29.
17. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulinelike growth factor binding protein in human in human plasma. Journal of Clinical Investigation 1986; 78, 1504-1512.
18. Frystyk J, Skjaerbaek C, Dinesen B et al. Free insulin-like growth factors (IGF I and IGF II) in human serum. FEBS letters 1994; 348: 185-191.
19. Khosla S, Kleerekepper M. Biochemical markers of bone turnover. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 1999: 128-134.
20. Pavelková A, Havelka S, Veselá M et al. Metabolické kostní ukazatele u difuzní idiopatické skeletá lní hyperostózy. Rheumatologia 2001; 15: 161-166.